Taking anticonvulsants increases the risk of suicide

According to a recent study by US scientists, the widespread use of anticonvulsants such as Pfizer and Trileptal Neurontin of Novartis, may increase the risk of suicide, deliberate self Death and violent death in patients who first took medicine.

The results of the study, published in the Journal of the American Medical Association (AMA), indicate that compared to Johnson & Johnson's new antiepileptic drugs like Topamax, the risk of suicide is higher among new users. Neurontin, Lamictal of GlaxoSmithKline, Trileptal or Gabitril of Cephalon.

Dr. Elisabetta Patorno, Brigham & Women's Hospital and Harvard Medical School in Boston, together with her colleagues, conducted research on the risk of suicidal actions and thoughts through the analysis of prescriptions and data. Clinical data of nearly 300,000 patients aged 15 and older.

These people have been prescribed anticonvulsants for the first time in the period of July 2001 to December 2006.

"We found increased risk for suicidal actions in the first 14 days after the first treatment. This suggests that anticonvulsants can cause behavioral effects, before they can promote full therapeutic effect, "said Dr. Patorno.

The research team identified nearly 830 suicidal actions including more than 800 suicidal acts of suicide and nearly 30 suicidal acts. In addition, they found that nearly 40 more deaths were violent.

However, Dr. Patorno also suggested that patients should continue to use the remedy, but must closely monitor and doctors weigh between the benefits and risks of drug use.

In 2008, the US Food and Drug Administration (FDA) requested that all anticonvulsant drugs need to post a warning about doubling the risk of suicidal behavior and thinking. ./.